“The validation of a multidimensional tool to test knowledge, barriers, and the challenges in screening for Tuberculosis among patients with Diabetes Mellitus”
Monisha Mary P , Ankeeta Menona Jacob , Avinash Shetty
{"title":"“The validation of a multidimensional tool to test knowledge, barriers, and the challenges in screening for Tuberculosis among patients with Diabetes Mellitus”","authors":"Monisha Mary P , Ankeeta Menona Jacob , Avinash Shetty","doi":"10.1016/j.ijtb.2024.04.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The National Coordination Committee (NCC) for the National Tuberculosis Elimination Programme (NTEP) has mandated bi-directional screening for Tuberculosis(TB) and Diabetes Mellitus(DM). The study aims to validate a multidimensional tool to assess the correct knowledge of TB and the barriers and facilitators to TB screening in DM patients.</div></div><div><h3>Aim/objectives</h3><div>To develop and validate a tool for assessing knowledge, barriers, and challenges in TB screening among DM patients by figuring out the Content Validity Ratios and Indices.</div></div><div><h3>Methods and materials</h3><div>A multidimensional scale using deductive methods was designed. Between January 2023 and March 2023, ten subject matter experts were contacted in person or by email to validate the tool. Item Impact Score (IIS, Face Validity), Lawshe's Content Validity Ratio (CVR), and Scale Content Validity Indices (CVI) for relevance were computed. For the final tool, only the items with Item Impact Scores of ≥1.5, CVRs of ≥0.62, and CVIs of ≥0.62 (p-value <0.05) were taken into consideration.</div></div><div><h3>Results</h3><div>The Item Impact Score (Face Validity) of all the items accepted as knowledge, barriers, and challenges for TB among DM patients was ≥1.5. Content Validity Ratios (CVR) for the usefulness of all items related to knowledge, barriers, and challenges for TB was ≥0.62. The Scale Content Validity Indices (for relevance), i.e., S-CVI (Average) and S-CVI (Proportional relevance), were ≥0.62 and all the items were accepted.</div></div><div><h3>Conclusions</h3><div>The score for Item Impact (IIS), Ratios for Content Validity (CVR), and Indices measuring the content validity of a scale (CVI) in all domains of the final tool were accepted, which contained 38 items.</div></div>","PeriodicalId":39346,"journal":{"name":"Indian Journal of Tuberculosis","volume":"72 3","pages":"Pages 283-289"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Tuberculosis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0019570724000684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The National Coordination Committee (NCC) for the National Tuberculosis Elimination Programme (NTEP) has mandated bi-directional screening for Tuberculosis(TB) and Diabetes Mellitus(DM). The study aims to validate a multidimensional tool to assess the correct knowledge of TB and the barriers and facilitators to TB screening in DM patients.
Aim/objectives
To develop and validate a tool for assessing knowledge, barriers, and challenges in TB screening among DM patients by figuring out the Content Validity Ratios and Indices.
Methods and materials
A multidimensional scale using deductive methods was designed. Between January 2023 and March 2023, ten subject matter experts were contacted in person or by email to validate the tool. Item Impact Score (IIS, Face Validity), Lawshe's Content Validity Ratio (CVR), and Scale Content Validity Indices (CVI) for relevance were computed. For the final tool, only the items with Item Impact Scores of ≥1.5, CVRs of ≥0.62, and CVIs of ≥0.62 (p-value <0.05) were taken into consideration.
Results
The Item Impact Score (Face Validity) of all the items accepted as knowledge, barriers, and challenges for TB among DM patients was ≥1.5. Content Validity Ratios (CVR) for the usefulness of all items related to knowledge, barriers, and challenges for TB was ≥0.62. The Scale Content Validity Indices (for relevance), i.e., S-CVI (Average) and S-CVI (Proportional relevance), were ≥0.62 and all the items were accepted.
Conclusions
The score for Item Impact (IIS), Ratios for Content Validity (CVR), and Indices measuring the content validity of a scale (CVI) in all domains of the final tool were accepted, which contained 38 items.
背景:国家消除结核病规划(NTEP)国家协调委员会(NCC)已授权对结核病(TB)和糖尿病(DM)进行双向筛查。该研究旨在验证一种多维工具,以评估对结核病的正确认识以及糖尿病患者结核病筛查的障碍和促进因素。目的:通过计算内容效度比和指标,开发并验证一种评估糖尿病患者结核病筛查知识、障碍和挑战的工具。方法与材料采用演绎法设计多维尺度。在2023年1月至2023年3月期间,我们亲自或通过电子邮件联系了10位主题专家,以验证该工具。计算项目影响评分(IIS, Face Validity)、Lawshe内容效度比(CVR)和量表内容效度指数(CVI)的相关性。对于最终工具,仅考虑项目影响评分≥1.5,cvr≥0.62,CVIs≥0.62 (p值<;0.05)的项目。结果DM患者结核病知识、障碍和挑战项目的影响分(面效度)均≥1.5。与结核病知识、障碍和挑战相关的所有项目的有用性的内容效度比(CVR)≥0.62。量表内容效度指标(相关性),即S-CVI(平均)和S-CVI(比例相关性)≥0.62,所有条目均被接受。结论最终工具的38个项目均接受了项目影响评分(IIS)、内容效度比(CVR)和衡量量表内容效度的指标(CVI)。
期刊介绍:
Indian Journal of Tuberculosis (IJTB) is an international peer-reviewed journal devoted to the specialty of tuberculosis and lung diseases and is published quarterly. IJTB publishes research on clinical, epidemiological, public health and social aspects of tuberculosis. The journal accepts original research articles, viewpoints, review articles, success stories, interesting case series and case reports on patients suffering from pulmonary, extra-pulmonary tuberculosis as well as other respiratory diseases, Radiology Forum, Short Communications, Book Reviews, abstracts, letters to the editor, editorials on topics of current interest etc. The articles published in IJTB are a key source of information on research in tuberculosis. The journal is indexed in Medline